Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INWK
5401
DELISTED
InnerWorkings, Inc.
INWK
| $73K | ﹤0.01% |
7,311
+5,517
| +308% | +$59.2K |
|
|
CCRN
5402
DELISTED
Cross Country Healthcare
CCRN
| $72K | ﹤0.01% |
5,618
+4,473
| +391% | +$59.1K |
|
5403
Direxion Daily Real Estate Bull 3X ETF
DRN
$45.7M
| $72K | ﹤0.01% |
+3,167
| New | +$72.8K |
|
|
EEX
5404
DELISTED
Emerald Holding
EEX
| $72K | ﹤0.01% |
3,566
+3,204
| +885% | +$70.9K |
|
5405
Globant
GLOB
$1.62B
| $72K | ﹤0.01% |
1,546
-1,635
| -51% | -$65.7K |
|
5406
Magnite
MGNI
$2.95B
| $72K | ﹤0.01% |
38,839
+33,013
| +567% | +$82.5K |
|
5407
Spok Holdings
SPOK
$232M
| $72K | ﹤0.01% |
4,631
+3,221
| +228% | +$54K |
|
5408
PUT
UBS Group
UBS
$176B
| $72K | ﹤0.01% |
3,900
-1,400
| -26% | -$24.3K |
|
5409
PUT
W.R. Berkley
WRB
$26.6B
| $72K | ﹤0.01% |
3,375
-1,688
| -33% | -$34.5K |
|
5410
York Water
YORW
$500M
| $72K | ﹤0.01% |
2,135
+1,837
| +616% | +$64.7K |
|
|
ZVO
5411
DELISTED
Zovio Inc. Common Stock
ZVO
| $72K | ﹤0.01% |
8,574
+8,141
| +1,880% | +$75.4K |
|
|
BKMU
5412
DELISTED
Bank Mutual Corp
BKMU
| $72K | ﹤0.01% |
6,758
+5,447
| +415% | +$57K |
|
5413
PUT
AGCO
AGCO
$7.49B
| $71K | ﹤0.01% |
1,000
+400
| +67% | +$28.5K |
|
5414
Sphere 3D
ANY
$18.3M
| $71K | ﹤0.01% |
+51
| New | +$71.9K |
|
5415
Arrow Financial
AROW
$678M
| $71K | ﹤0.01% |
2,486
+1,915
| +335% | +$56.5K |
|
5416
Anavex Life Sciences
AVXL
$305M
| $71K | ﹤0.01% |
22,107
-1,047
| -5% | -$4.12K |
|
5417
Babcock & Wilcox
BW
$1.53B
| $71K | ﹤0.01% |
1,247
-2,168
| -63% | -$98.3K |
|
5418
Forestar Group
FOR
$1.5B
| $71K | ﹤0.01% |
3,215
-21,026
| -87% | -$409K |
|
|
NVEE
5419
DELISTED
NV5 Global
NVEE
| $71K | ﹤0.01% |
5,276
+2,396
| +83% | +$32.5K |
|
5420
PUT
OneSpan
OSPN
$601M
| $71K | ﹤0.01% |
5,100
+1,800
| +55% | +$23.8K |
|
|
VBTX
5421
DELISTED
Veritex Holdings
VBTX
| $71K | ﹤0.01% |
2,566
+2,191
| +584% | +$59.2K |
|
|
VSI
5422
DELISTED
Vitamin Shoppe Inc.
VSI
| $71K | ﹤0.01% |
16,028
-158,864
| -91% | -$699K |
|
|
CSBK
5423
DELISTED
Clifton Bancorp Inc.
CSBK
| $71K | ﹤0.01% |
4,180
+3,434
| +460% | +$58.3K |
|
5424
CALL
Douglas Emmett
DEI
$2.01B
| $70K | ﹤0.01% |
1,700
+1,600
| +1,600% | +$64.6K |
|
|
EUHY
5425
iShares Euro High Yield Corporate Bond USD Hedged ETF
EUHY
$246M
| $70K | ﹤0.01% |
1,286
| – | – |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.